Skip to main content
Content Starts Here GSA Federal Advisory Committee Act (FACA) Database Skip to main content

Committee Detail

Note: An Annual Comprehensive Review, as required by §7 of the Federal Advisory Committee Act, is conducted each year on committee data entered for the previous fiscal year (referred to as the reporting year). The data for the reporting year is not considered verified until this review is complete and the data is moved to history for an agency/department. See the Data From Previous Years section at the bottom of this page for the committee’s historical, verified data.


HHS - 810 - Board of Scientific Counselors, National Institute on Drug Abuse - Authorized by Law
Hide Section - GENERAL INFORMATION

GENERAL INFORMATION

Committee NameBoard of Scientific Counselors, National Institute on Drug AbuseAgency NameDepartment of Health and Human Services
Fiscal Year2020Committee Number810
Original Establishment Date8/27/1980Committee StatusChartered
Actual Termination Date Committee URL 
New Committee This FYNoPresidential Appointments*No
Terminated This FYNoMax Number of Members*14
Current Charter Date10/31/2005Designated Fed Officer Position Title*Management Analyst, IRP, NIDA
Date Of Renewal Charter Designated Federal Officer PrefixMs.
Projected Termination Date Designated Federal Officer First Name*Adrienne
Exempt From Renewal*YesDesignated Federal Officer Middle NameG.
Specific Termination AuthorityDesignated Federal Officer Last Name*Snyder
Establishment Authority*Authorized by LawDesignated Federal Officer Suffix
Specific Establishment Authority*42 U.S.C. 282(b)(16)Designated Federal Officer Phone*(443) 740-2394
Effective Date Of Authority*8/27/1980Designated Federal Officer Fax*443-740-2865
Exempt From EO 13875 Discretionary CmteExempt: Merit Review PanelDesignated Federal Officer Email*adrienne.snyder@nih.gov
Committee Type*Continuing
Presidential*No
Committee Function*Other Committee
Hide Section - RECOMMENDATION/JUSTIFICATIONS

RECOMMENDATION/JUSTIFICATIONS

Agency Recommendation*Continue
Legislation to Terminate RequiredNot Applicable
Legislation StatusNot Applicable
How does cmte accomplish its purpose?*The committee is composed of recognized biomedical and/or behavioral research authorities who represent the forefront of research and technical knowledge and who provide evaluation and peer review of Institute laboratories and senior scientists in the areas of sociology, psychology, psychiatry, biochemistry, physiology, pharmacology, endocrinology, neurosciences, and related biological and behavioral sciences. During this reporting period the Board evaluated the productivity and performance of senior scientists of the Neuronal Circuits & Behavior Unit, Cellular Neurobiology Research Branch; Neural Engineering Unit, Behavioral Neuroscience Research Branch; Designer Drug Research Unit, Office of the Scientific Director; Molecular Neuropsychiatry Research Section, Molecular Neuropsychiatry Research Branch; Integrative Neurobiology Section, Molecular Targets & Medications Discovery Branch; and Behavioral Neurophysiology Neuroscience Section, Cellular Neurobiology Research Branch.
How is membership balanced?*The Board consists of 14 members who are outstanding authorities knowledgeable in the specialized fields of sociology, psychology, psychiatry, biochemistry, physiology, pharmacology, endocrinology, neuroscience, and related biological and behavior sciences related to the intramural research activities of the Institute. The advisory role of the Board is scientific and substantive. The Board, through periodic visits to the laboratories, assesses the research in progress and evaluates productivity and performance of senior scientists.
How frequent & relevant are cmte mtgs?*The Board met twice during this reporting period on November 21, 2019 and May 7-8, 2020. The Board holds approximately two meetings each year for the peer review of intramural laboratories on a rotating basis as required by the PHS Act. Board evaluated the productivity and performance of senior scientists of the Neuronal Circuits & Behavior Unit, Cellular Neurobiology Research Branch; Neural Engineering Unit, Behavioral Neuroscience Research Branch; Designer Drug Research Unit, Office of the Scientific Director; Molecular Neuropsychiatry Research Section, Molecular Neuropsychiatry Research Branch; Integrative Neurobiology Section, Molecular Targets & Medications Discovery Branch; and Behavioral Neurophysiology Neuroscience Section, Cellular Neurobiology Research Branch. The Chair also participated in another activity on the following date: 5/15/2020.
Why advice can't be obtained elsewhere?*This committee is composed of recognized biomedical and/or behavioral research authorities from outside the NIH in order to secure unbiased and objective evaluation of intramural research programs. Their recommendations are invaluable because the complex nature of research in each laboratory requires a unique balance and breadth of expertise not available on the NIH staff or from other established resources.
Why close or partially close meetings?The meetings of the Board of Scientific Counselors, NIDA, were closed for the review, discussion, and evaluation of individual programs and projects conducted by the Institute, including consideration of personnel qualifications and performance, the competence of individual investigators, and similar items, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Section 552b(c)(6) of the Government in the Sunshine Act permits the closing of meetings where discussion could reveal personal information, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.
Recommendation RemarksCommittee Function: Other - Scientific and Technical Peer Review.

Members: Regina Carelli was appointed as chair. As such, her designation as a member has been changed to chair. Michela Marinelli was reappointed. As such, her term of service end date is different then what was reported on the FY19 ACR. Jennifer Mitchell resigned from the committee on April 20, 2020 and and T. Celeste Napier resigned on August 1, 2020.

Reports: This committee did not produce any reports during this reporting period.

Website: This committee does not have a dedicated website.

The DFO and Committee Decision Maker positions have changed to Adrienne G. Snyder. They are held by the same individual based on assigned duties within the IC.
Hide Section - PERFORMANCE MEASURES

PERFORMANCE MEASURES

Outcome Improvement To Health Or Safety*NoAction Reorganize Priorities*No
Outcome Trust In GovernmentNoAction Reallocate ResourcesNo
Outcome Major Policy ChangesNoAction Issued New RegulationsNo
Outcome Advance In Scientific ResearchYesAction Proposed LegislationNo
Outcome Effective Grant MakingNoAction Approved Grants Or Other PaymentsNo
Outcome Improved Service DeliveryNoAction OtherNo
Outcome Increased Customer SatisfactionNoAction CommentThe Scientific Director and other NIH officials use the recommendations made by the BSC in evaluating the quality of the intramural research programs including scientific priorities and resources available. No changes were made to existing laboratory research priorities or resources.
Outcome Implement Laws/Reg RequirementsNoGrants Review*No
Outcome OtherNoNumber Of Grants Reviewed0
Outcome CommentNANumber Of Grants Recommended0
Cost Savings*Unable to DetermineDollar Value Of Grants Recommended$0.00
Cost Savings CommentNIH supported basic and clinical research accomplishments often take many years to unfold into new diagnostic tests and new ways to treat and prevent diseases.Grants Review CommentAlthough grant reviews are included in the duties of this Board, there were no grant reviews performed during this fiscal year. Intramural Research is not funded by grants.
Number Of Recommendations*98Access Contact Designated Fed. Officer*Yes
Number Of Recommendations CommentThe Committee makes recommendations based on the strengths and weaknesses of each scientist’s research program, including space and resource allocations, and reviews the scientist’s mentoring record.Access Agency WebsiteYes
% of Recs Fully Implemented*0.00%Access Committee WebsiteNo
% of Recs Fully Implemented CommentInformation on the research funded by NIH is available through the RePORT (Research Portfolio Online Reporting Tool) website. RePORT provides access to reports, data, and analyses of NIH research activities that advance the mission of the NIH, including information on NIH expenditures, strategic plans, reports on NIH funding, and reports on the organization and people involved in NIH research and research training. The RePORT website is located at http://report.nih.gov.Access GSA FACA WebsiteYes
% of Recs Partially Implemented*0.00%Access PublicationsNo
% of Recs Partially Implemented CommentInformation on the research funded by NIH is available through the RePORT (Research Portfolio Online Reporting Tool) website. RePORT provides access to reports, data, and analyses of NIH research activities that advance the mission of the NIH, including information on NIH expenditures, strategic plans, reports on NIH funding, and reports on the organization and people involved in NIH research and research training. The RePORT website is located at http://report.nih.gov.Access OtherYes
Agency Feedback*YesAccess CommentContact the National Institute on Drug Abuse Committee Management Office.
Agency Feedback Comment*The NIDA Scientific Director provides written feedback to the committee regarding actions taken based on the committee’s recommendations.Narrative Description*Section 402(b)(3) of the Public Health Service Act states that “the Director, NIH shall assure that research at the National Institutes of Health is subject to review in accordance with section 492.” Section 492(b) states that the “Director of NIH shall establish procedures for periodic technical and scientific peer review of research at the National Institutes of Health. The mission of the Board of Scientific Counselors is to assess the quality of the Institute’s intramural research programs and to evaluate the productivity and performance of intramural scientists and shall also, as requested by the Director, NIH, undertake peer review of extramural funding applications as required by section 492 of the Public Health Service Act, as amended.”
Hide Section - COSTS

COSTS

Payments to Non-Federal Members*$4,400.00Est Payments to Non-Fed Members Next FY*$4,400.00
Payments to Federal Members*$0.00Est. Payments to Fed Members Next FY* 
Payments to Federal Staff*$68,055.00Estimated Payments to Federal Staff*$69,824.00
Payments to Consultants*$4,400.00Est. Payments to Consultants Next FY*$4,400.00
Travel Reimb. For Non-Federal Members*$5,147.00Est Travel Reimb Non-Fed Members nextFY*$5,176.00
Travel Reimb. For Federal Members*$0.00Est Travel Reimb For Fed Members* 
Travel Reimb. For Federal Staff*$0.00Est. Travel Reimb to Fed Staff Next FY* 
Travel Reimb. For Consultants*$4,289.00Est Travel Reimb to Consultants Next FY*$4,315.00
Other Costs$264.00Est. Other Costs Next FY*$267.00
Total Costs$86,555.00Est. Total Next FY*$88,382.00
Federal Staff Support (FTE)*0.40Est. Fed Staff Support Next FY*0.40
Cost RemarksDue to the COVID-19 pandemic, FY2020 meetings held after March 12, 2020 were virtual only, which reduced committee operating costs. If face to face meetings resume, committee costs for FY2021 may be higher.Est Cost Remarks
Hide Section - Interest Areas

Interest Areas

Category
Area
Health
Health Care
Medicine
Health and Health Research
Research
Basic Research
Hide Section - MEMBERS,MEETINGS AND ADVISORY REPORTS

MEMBERS,MEETINGS AND ADVISORY REPORTS

To View all the members, meetings and advisory reports for this committee please click here
Hide Section - CHARTERS AND RELATED DOCS

CHARTERS AND RELATED DOCS

No Documents Found
Hide Section - DATA FROM PREVIOUS YEARS

DATA FROM PREVIOUS YEARS

Committee

Data from Previous Years

 
ActionCommittee System IDCommittee NameFiscal Year
 COM-036652Board of Scientific Counselors, National Institute on Drug Abuse2019
 COM-034867Board of Scientific Counselors, National Institute on Drug Abuse2018
 COM-001886Board of Scientific Counselors, National Institute on Drug Abuse2017
 COM-002366Board of Scientific Counselors, National Institute on Drug Abuse2016
 COM-004018Board of Scientific Counselors, National Institute on Drug Abuse2015
 COM-004357Board of Scientific Counselors, National Institute on Drug Abuse2014
 COM-006118Board of Scientific Counselors, National Institute on Drug Abuse2013
 COM-006594Board of Scientific Counselors, National Institute on Drug Abuse2012
 COM-008262Board of Scientific Counselors, National Institute on Drug Abuse2011
 COM-008897Board of Scientific Counselors, National Institute on Drug Abuse2010
 COM-010421Board of Scientific Counselors, National Institute on Drug Abuse2009
 COM-010720Board of Scientific Counselors, National Institute on Drug Abuse2008
 COM-011961Board of Scientific Counselors, National Institute on Drug Abuse2007
 COM-012666Board of Scientific Counselors, National Institute on Drug Abuse2006
 COM-013933Board of Scientific Counselors, National Institute on Drug Abuse2005
 COM-014755Board of Scientific Counselors, National Institute on Drug Abuse2004
 COM-015658Board of Scientific Counselors, National Institute on Drug Abuse2003
 COM-016453Board of Scientific Counselors, National Institute on Drug Abuse2002
 COM-017837Board of Scientific Counselors, National Institute on Drug Abuse2001
 COM-018376Board of Scientific Counselors, National Institute on Drug Abuse2000
 COM-019770Board of Scientific Counselors, National Institute on Drug Abuse1999
 COM-020627Board of Scientific Counselors, National Institute on Drug Abuse1998
 COM-021426Board of Scientific Counselors, National Institute on Drug Abuse1997